Sonormed

Sonormed GmbH, a Hamburg-based company established in 2012, operates in the digital audiology and e-health sector, specializing in therapeutic solutions for tinnitus. The company was founded by Jörg Land, who serves as CEO and oversees marketing and business development, alongside Adrian Nötzel (an audio engineer) and Matthias Lanz (a computer scientist). The founding was spurred by a clinic's request to develop a widely accessible technology based on positive results from their research on tinnitus therapy.

Sonormed's core business revolves around developing and marketing digital health applications (DiGAs) that are available by prescription and reimbursed by statutory health insurance funds in Germany. The company's primary market consists of individuals suffering from subjective, chronic, tonal tinnitus. Its business model is centered on providing these digital therapies to patients, prescribed through ENT specialists and audiologists. A significant milestone was the acquisition of Sonormed by InfectoPharm Arzneimittel und Consilium GmbH in January 2025, a move intended to further expand the reach of Sonormed's digital applications. Jörg Land continues to manage the tinnitus app product line within the new parent company.

The company's flagship product evolved from "Tinnitracks" to the "Meine Tinnitus App". Tinnitracks, launched in 2015, was a pioneering web and mobile application that utilized a neuroscientific approach called Tailor-Made Notched Music Training (TMNMT). This therapy works by filtering a patient's own music to remove the specific sound frequencies corresponding to their individual tinnitus. The process requires a precise diagnosis from an ENT doctor to determine the exact tinnitus frequency. By listening to this filtered music, the therapy aims to reduce the hyperactivity of specific nerve cells in the brain's auditory cortex, which is believed to be the cause of tinnitus, thereby addressing the root cause rather than just managing symptoms. In 2022, the company launched "Meine Tinnitus App," which was approved as a DiGA and is permanently listed for reimbursement by German health authorities. This app's clinical effectiveness in reducing tinnitus-related stress has been demonstrated in studies.

Keywords: digital health, audiology, tinnitus treatment, DiGA, digital therapeutics, e-health, medical app, prescription app, neuroplasticity, notched music therapy, Jörg Land, Tinnitracks, Meine Tinnitus App, hearing health, ENT solutions, medical software, InfectoPharm, digital patient care, sound engineering, chronic tinnitus